FDA Fertility & Maternal Health Drugs Advisory Committee
Executive Summary
Oct. 29 meeting agenda includes use of betamimetic drugs for tocolysis. Discussion includes perinatal benefits and maternal risks of preterm labor management with Astra's Yutopar (ritodrine). The review was scheduled after publication of a study that showed beta- adrenergic agonist therapy offers "no significant" benefit in reducing mortality, prolonging pregnancy to term or improving birth weight.